Searched for: in-biosketch:true
person:deleoj07
Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin A
Voloshyna, Iryna; Teboul, Isaac; Kasselman, Lora J; Salama, Michael; Carsons, Steven E; DeLeon, Joshua; Mattana, Joseph; Miyawaki, Nobuyuki; Reiss, Allison B
OBJECTIVE:Mycophenolate (MPA) and cyclosporin A (CsA) are two immunosuppressive agents currently used for the treatment of autoimmune diseases. However, reports regarding their effects on inflammation and lipid handling are controversial. Here, we compare the effect of these two drugs on the expression of proteins involved in cholesterol handling and lipid accumulation in a macrophage cell system utilizing M0, M1 and M2 human macrophages and in murine bone marrow-derived macrophages (BMDM). METHODS:. RESULTS:In M0 macrophages, MPA increased expression of ABCA1 and CXCL16 in a concentration-dependent manner. In M1 THP-1 macrophages, MPA caused a significant increase of 27-hydroxylase mRNA and CD36 and SR-A1 receptor mRNAs. Exposure of M2 macrophages to MPA also stimulated expression of 27-hydroxylase, while downregulating all evaluated scavenger receptors. In contrast, CsA had no impact on cholesterol efflux in M0 and M1 macrophages, but significantly augmented expression of ABCA1 and 27-hydroxylase in M2 macrophages. CsA significantly increased expression of the LOX1 receptor in naïve macrophages, downregulated expression of CD36 and SR-A1 in the M1 subpopulation and upregulated expression of all evaluated scavenger receptors. However, CsA enhanced foam cell transformation in M0 and M2 macrophages, while MPA had no effect on foam cell formation unless used at a high concentration in the M2 subtype. CONCLUSIONS:Our results clearly underline the importance of further evaluation of the effects of these drugs when used in atherosclerosis-prone patients with autoimmune or renal disease.
PMID: 31227843
ISSN: 1420-908x
CID: 3954772
Adenosine and the Cardiovascular System
Reiss, Allison B; Grossfeld, David; Kasselman, Lora J; Renna, Heather A; Vernice, Nicholas A; Drewes, Wendy; Konig, Justin; Carsons, Steven E; DeLeon, Joshua
Adenosine is an endogenous nucleoside with a short half-life that regulates many physiological functions involving the heart and cardiovascular system. Among the cardioprotective properties of adenosine are its ability to improve cholesterol homeostasis, impact platelet aggregation and inhibit the inflammatory response. Through modulation of forward and reverse cholesterol transport pathways, adenosine can improve cholesterol balance and thereby protect macrophages from lipid overload and foam cell transformation. The function of adenosine is controlled through four G-protein coupled receptors: A1, A2A, A2B and A3. Of these four, it is the A2A receptor that is in a large part responsible for the anti-inflammatory effects of adenosine as well as defense against excess cholesterol accumulation. A2A receptor agonists are the focus of efforts by the pharmaceutical industry to develop new cardiovascular therapies, and pharmacological actions of the atheroprotective and anti-inflammatory drug methotrexate are mediated via release of adenosine and activation of the A2A receptor. Also relevant are anti-platelet agents that decrease platelet activation and adhesion and reduce thrombotic occlusion of atherosclerotic arteries by antagonizing adenosine diphosphate-mediated effects on the P2Y12 receptor. The purpose of this review is to discuss the effects of adenosine on cell types found in the arterial wall that are involved in atherosclerosis, to describe use of adenosine and its receptor ligands to limit excess cholesterol accumulation and to explore clinically applied anti-platelet effects. Its impact on electrophysiology and use as a clinical treatment for myocardial preservation during infarct will also be covered. Results of cell culture studies, animal experiments and human clinical trials are presented. Finally, we highlight future directions of research in the application of adenosine as an approach to improving outcomes in persons with cardiovascular disease.
PMID: 30972618
ISSN: 1179-187x
CID: 3854092
ATHEROPROTECTIVE ACTIONS OF OXYTOCIN IN HUMAN MACROPHAGES: REDUCED LIPID ACCUMULATION UNDER INFLAMMATORY CONDITIONS
Karten, Ariel; Kasselman, Lora; Renna, Heather A; Lam, Eric; Glass, Daniel S; Vernice, Nicholas A; DeLeon, Joshua; Reiss, Allison
CINAHL:135346080
ISSN: 0735-1097
CID: 3818992
Is intra-procedure three-dimensional transesophageal echocardiogram an alternative to preprocedure multidetector computed tomography for the measurement of the aortic annulus in patients undergoing transcatheter aortic valve replacement?
Hafiz, Abdul Moiz; Medranda, Giorgio A; Kakouros, Nikolaos; Patel, Jay; Kahan, Jonathan; Gubernikoff, George; Ray, Beevash; Paruchuri, Vijayapraveena; DeLeon, Joshua; Marzo, Kevin; Calixte, Rose; Gaztanaga, Juan
BACKGROUND:The role of three-dimensional transesophageal echocardiography (3DTEE) vs multidetector computed tomography (MDCT) in aortic annular sizing has been poorly defined in patients undergoing transcatheter aortic valve replacements (TAVR). We set to determine the correlation between 3DTEE and MDCT in measuring the aortic annulus prior to TAVR. METHODS:In an observational, retrospective study, we compared aortic annular areas measured by MDCT and 3DTEE in TAVR patients. The aortic annular area was measured by planimetry of images obtained by MDCT pre-TAVR and by intra-TAVR TEE using 3D rendering of the aortic annulus followed by planimetry. Our primary outcome was degree of correlation between mean aortic annulus area by 3DTEE and MDCT. RESULTS:. There was a strong positive linear correlation between aortic annular area measurements obtained from these two modalities with mild relative underestimation by 3DTEE (Ï=.833). This relationship can be estimated using the predictive formula: [Formula: see text] CONCLUSIONS: Three-dimensional transesophageal echocardiography measurements have a high degree of correlation with MDCT measurements and thus can assist in proper valve prosthesis selection for TAVR. Our study thus supports use of 3DTEE as a reasonable alternative imaging modality in patients undergoing TAVR.
PMID: 28722306
ISSN: 1540-8175
CID: 3406942
PRO-ATHEROGENIC PROPERTIES OF PLASMA FROM PATIENTS WITH TYPE 1 DIABETES MELLITUS: EFFECTS ON MACROPHAGE LIPID HANDLING [Meeting Abstract]
DeLeon, Joshua R; Corletto, Jorge Mejia; Accacha, Siham; Voloshyna, Iryna; Siegart, Nicolle; Kasselman, Lora; Magana, Mariano Castro; Reiss, Allison
ISI:000397342302789
ISSN: 1558-3597
CID: 2677992
Impact of first contact on symptom onset-to-door time in patients presenting for primary percutaneous coronary intervention
Hafiz, Abdul Moiz; Naidu, Srihari S; DeLeon, Joshua; Islam, Shahidul; Alkhatib, Basil; Lorenz, Miguel; D'Elia, Alexis; Rosenthal, Barry; Marzo, Kevin
OBJECTIVES/OBJECTIVE:To determine effect of first medical contact type on symptom onset-to-door time (SODT). BACKGROUND:Shorter total ischemic time is associated with improved outcomes in ST-elevation myocardial infarction. METHODS:From 2005 to 2009, we reviewed records of all consecutive patients treated with primary percutaneous coronary intervention for ST-elevation myocardial infarction at our tertiary care teaching hospital (median follow-up 3.85 years). We compared SODT in patients whose first medical contact was a private physician (in person or via telephone) vs patients who presented to the emergency department (ED) directly (in person or via Emergency Medical Services). RESULTS:Of 366 patients, 84 (23%) contacted a physician (group A) while 282 (77.6%) did not (group B). Group A had higher median SODT (239.5 vs 130 minutes, P = .0043) and significantly higher mortality (log rank P = .0392, Cox Proportional Hazard Model risk factors: physician contact first [P < .013], age [P < .0001] and peripheral vascular disease [P < .035]). Two factors associated with prolonged SODT: (1) contacting a physician first P = .002 and (2) personal mode of transportation, P = .002. Patients presenting during "on-hours" (weekdays) were more likely to first contact a physician compared with those presenting during "off-hours" (weeknights and weekends) (66.67% in group A vs 45.04% in group B, P < .001). CONCLUSIONS:Patients whose first medical contact was a physician had greater pre-hospital delays and worse survival compared to those who sought emergent medical care directly. This pattern occurred more often during "on-hours." Educational efforts aimed at both patient and physician office practices are warranted.
PMID: 23623235
ISSN: 1532-8171
CID: 3406932
IMMEDIATE AND EARLY EFFECTS OF ALCOHOL SEPTAL ABLATION ON THE RIGHT HEART AND LEFT ATRIUM [Meeting Abstract]
Ray, Beevash; Lachmann, Justine; Cohen, Jerald L.; Gubernikoff, George; DeLeon, Joshua R.; Gaztanaga, Juan; Michelakis, Nickolaos; Naidu, Srihari S.
ISI:000302326700243
ISSN: 0735-1097
CID: 3406922
Circulating endothelial microparticles in diabetes mellitus
Tramontano, A F; Lyubarova, R; Tsiakos, J; Palaia, T; Deleon, J R; Ragolia, L
BACKGROUND:Endothelial Microparticles (EMPs) are small vesicles shed from activated or apoptotic endothelial cells and involved in cellular cross-talk. Whether EMP immunophenotypes vary according to stimulus in Diabetes Mellitus (DM) is not known. We studied the cellular adhesion molecule (CAM) profile of circulating EMPs in patients with and without Diabetes Mellitus type 2, who were undergoing elective cardiac catheterization. METHODS AND RESULTS/RESULTS:EMPs were analyzed by flow cytometry. The absolute median number of EMPs (EMPs/microL) specific for CD31, CD105, and CD106 was significantly increased in the DM population. The ratio of CD62E/CD31 EMP populations reflected an apoptotic process. CONCLUSION/CONCLUSIONS:Circulating CD31+, CD105+, and CD106+ EMPs were significantly elevated in patients with DM. EMPs were the only independent predictors of DM in our study cohort. In addition, the EMP immunophenotype reflected an apoptotic process. Circulating EMPs may provide new options for risk assessment.
PMCID:2904448
PMID: 20634911
ISSN: 1466-1861
CID: 4954992
Prostaglandin D2 synthase isoforms and diabetic vasculopathy [Meeting Abstract]
Tramontano, Anthony F.; Hall, Christopher; Kodali, Visali; DeLeon, Joshua R.; Ragolia, Louis
ISI:000253997102127
ISSN: 0735-1097
CID: 3406912
Adherence to the American college oi cardiology/American society of nuclear cardiology appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging [Meeting Abstract]
Kerwin, Todd C.; Lo, Ronald; D'Anca, Michael; DeLeon, Joshua R.
ISI:000244651801072
ISSN: 0735-1097
CID: 3388342